13F HOLDINGS REPORT
M28 Capital Management LP
Quarter ended Q2 2024 · Filed August 13, 2024 · Accession 0000902664-24-005090
Total Value
$77.1M
Positions
11
Other Managers
0
Confidential Omitted
No
Holdings (11)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | WAVE LIFE SCIENCES LTD | WVE | 6,164,548 | $30.8M | 39.88% |
| 2 | INVIVYD INC | IVVD | 9,248,250 | $10.2M | 13.19% |
| 3 | ROCKET PHARMACEUTICALS INC | RCKTW | 385,680 | $8.3M | 10.76% |
| 4 | FRACTYL HEALTH INC | GUTS | 1,856,117 | $7.9M | 10.27% |
| 5 | SPRINGWORKS THERAPEUTICS INC | 85205L107 | 110,400 | $4.2M | 5.39% |
| 6 | SILENCE THERAPEUTICS PLC | SLNCF | 185,100 | $3.5M | 4.56% |
| 7 | BRIDGEBIO PHARMA INC | BBIO | 121,200 | $3.1M | 3.98% |
| 8 | CURIS INC | CRIS | 421,951 | $2.9M | 3.77% |
| 9 | TG THERAPEUTICS INC | TGTX | 161,600 | $2.9M | 3.73% |
| 10 | ARROWHEAD PHARMACEUTICALS IN | ARWR | 67,400 | $1.8M | 2.27% |
| 11 | PROQR THRAPEUTICS N V | N71542109 | 1,019,498 | $1.7M | 2.19% |